Director of Biostatistics - Phase Lead PH-ILD Trials
Listed on 2026-10-09
-
Research/Development
Pulmovant is seeking a Director of Biostatistics to lead statistical strategy for its Phase 3 PHrontier program evaluating mosliciguat in PH-ILD. You will partner with Clinical Development, Regulatory, and Data Management to ensure rigorous, submission-ready trial design and analysis.
The ideal candidate has 8+ years in clinical drug development, PhD or MS in Biostatistics, and direct Phase 3 experience, including regulatory submissions.
This Full Time position is for the Director of Biostatistics
- Phase 3 Lead for PH-ILD Trials role at Pulmovant.
Take a moment to read everything above and see whether this role is right for you.
This posting is for the Director of Biostatistics
- Phase 3 Lead for PH-ILD Trials role at Pulmovant, based in United States.
We are looking to fill the Director of Biostatistics
- Phase 3 Lead for PH-ILD Trials position at Pulmovant in United States.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).